This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Johann Bosson: Innovator in Kinase Inhibitors
Introduction
Johann Bosson is a notable inventor based in Etrembières, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His work is crucial for advancing treatments for various diseases, including cancer.
Latest Patents
Johann Bosson holds a patent for "Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors." This invention relates to a specific class of compounds that can inhibit kinase activity, which is vital in the treatment of cancer. The patent outlines various chemical structures and their potential applications in therapeutic settings.
Career Highlights
Bosson is affiliated with the Centre National de la Recherche Scientifique, where he conducts research and development in the field of biochemistry. His innovative work has led to advancements in understanding how kinase inhibitors can be utilized in cancer treatment.
Collaborations
He has collaborated with esteemed colleagues such as Philippe Olivier Belmont and Laurent Meijer. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Johann Bosson's contributions to the field of kinase inhibitors exemplify the impact of innovative research on medical science. His work continues to pave the way for new therapeutic options in cancer treatment.